Leukemia inhibitory factor receptor (LIFR) is detected as a novel suppressor gene of hepatocellular carcinoma using double-combination array
Y Okamura, S Nomoto, M Kanda, Q Li, Y Nishikawa… - Cancer letters, 2010 - Elsevier
Y Okamura, S Nomoto, M Kanda, Q Li, Y Nishikawa, H Sugimoto, N Kanazumi, S Takeda…
Cancer letters, 2010•ElsevierHepatocellular carcinoma (HCC) is one of the world's top five causes of cancer-related
deaths and treatment options are limited in this type of cancer. In the present study, we
attempt to identify the novel suppressor genes of HCC using a double-combination array we
designed. Leukemia inhibitory factor receptor (LIFR) is one of suppressor genes using this
method. We found that 23 of 48 (47.9%) tumor tissues showed promoter hypermethylation of
LIFR gene, and the expression level was clearly reduced in tumor tissues (P< 0.0001). The …
deaths and treatment options are limited in this type of cancer. In the present study, we
attempt to identify the novel suppressor genes of HCC using a double-combination array we
designed. Leukemia inhibitory factor receptor (LIFR) is one of suppressor genes using this
method. We found that 23 of 48 (47.9%) tumor tissues showed promoter hypermethylation of
LIFR gene, and the expression level was clearly reduced in tumor tissues (P< 0.0001). The …
Hepatocellular carcinoma (HCC) is one of the world’s top five causes of cancer-related deaths and treatment options are limited in this type of cancer. In the present study, we attempt to identify the novel suppressor genes of HCC using a double-combination array we designed. Leukemia inhibitory factor receptor (LIFR) is one of suppressor genes using this method. We found that 23 of 48 (47.9%) tumor tissues showed promoter hypermethylation of LIFR gene, and the expression level was clearly reduced in tumor tissues (P<0.0001). The present study suggests that our method is a meaning technique able to detect novel genes and that LIFR gene is a new suppressor gene of HCC.
Elsevier